A type of cancer that starts from cells that become certain white blood cells in the bone marrow. The cancer cells start in the bone marrow but then go into the blood.
(Source: American Cancer Society)
Join our social circle:
Oncolytics Biotech® Inc. Enters into First-in-Class Collaboration with Myeloma UK and Celgene Using REOLYSIN® in Combination with Imnovid® or Revlimid® in Patients with Myeloma Read More
Oncolytics Biotech® Inc. Announces 2016 Year-End Results Read More
Exploring REOLYSIN®’s Objective Response Rate in Females with Colorectal Cancer Read More
Oncolytics Biotech® Inc. Enters into First-in-Class Collaboration w Myeloma UK and Celgene Using REOLYSIN® [cont'd] https://t.co/jNgmG6UZP6
Oncolytics Biotech® Inc. Collaborators Present Initial Results from REO 019 Study..[cont'd] https://t.co/dFjpBUiufH